Peritoneal Neoplasms Clinical Trials

68 clinical trials for Peritoneal Neoplasms across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — RECRUITING · PHASE3
• Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers — RECRUITING · PHASE2
• Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy — RECRUITING · NA
• MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) — RECRUITING · PHASE3
• Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers — RECRUITING · NA
• Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers — COMPLETED
• Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis — COMPLETED · PHASE2
• Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK-001/ENGOT-ov43/GOG-3036) — COMPLETED · PHASE3
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — ACTIVE_NOT_RECRUITING · PHASE3
• Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors — TERMINATED · PHASE1
• Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer — NOT_YET_RECRUITING · PHASE1
• AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer — COMPLETED · PHASE4
• PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer — COMPLETED · PHASE1
• Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer. — COMPLETED · PHASE1
• SUROVA - Surgery in Ovarian Cancer, Comparing Primary and Interval Cytoreductive Surgery — OTHER
• Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC — WITHDRAWN · NA
• A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — COMPLETED · PHASE3
• Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy - — COMPLETED · PHASE2
• Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer — COMPLETED · PHASE3
• Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases — OTHER · PHASE2
• Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube Cancer — COMPLETED · PHASE1
• Adjuvant HIPEC in High Risk Colon Cancer — COMPLETED · PHASE3
• Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy — COMPLETED
• Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer — COMPLETED · PHASE3
• Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis — COMPLETED · PHASE3
• Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors — COMPLETED · PHASE1
• A two-part, multicentre, international phase I and II trial assessing the safety and efficacy of the Hsp90 inhibitor ganetespib in combination with paclitaxel weekly in women with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer — OTHER
• HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis or Sarcomatosis - Data Registry — COMPLETED
• A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors — COMPLETED · PHASE1
• ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Carcinoma — TERMINATED · PHASE1
• PIPAC for Peritoneal Metastases of Colorectal Cancer — COMPLETED · PHASE2
• An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA) — COMPLETED
• Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies — COMPLETED · NA
• A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — COMPLETED · PHASE3
• EDMONd - Elemental Diet in Bowel Obstruction — OTHER · NA
• Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy — COMPLETED · NA
• Quality of Life Study for Pediatric and Adult Patients Undergoing Hyperthermic Peritoneal Perfusion With Cisplatin — COMPLETED
• Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas — COMPLETED · PHASE2
• LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer — COMPLETED · PHASE3
• Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer — TERMINATED · PHASE2
• Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT — COMPLETED · PHASE2
• A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis — TERMINATED · PHASE2
• Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy — COMPLETED · PHASE1
• OVCA-NAC-P2: Study of Chemotherapy Followed by Cytoreductive Surgery for Ovarian, Tubal and Peritoneal Cancers: JCOG0206 — COMPLETED · PHASE2
• OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer — COMPLETED · PHASE3
• Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy — COMPLETED · PHASE2

Refine this search